8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.22%
Revenue growth at 75-90% of 3391.T's 2.66%. Bill Ackman would push for innovation or market expansion to catch up.
0.43%
Gross profit growth under 50% of 3391.T's 3.30%. Michael Burry would be concerned about a severe competitive disadvantage.
3.96%
EBIT growth below 50% of 3391.T's 14.37%. Michael Burry would suspect deeper competitive or cost structure issues.
4.58%
Operating income growth under 50% of 3391.T's 14.37%. Michael Burry would be concerned about deeper cost or sales issues.
3.45%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
3.44%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
3.44%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3391.T is at 0.06%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
4.61%
OCF growth at 75-90% of 3391.T's 5.38%. Bill Ackman would demand better working capital management or cost discipline.
4.61%
FCF growth 75-90% of 3391.T's 5.38%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
24.33%
10Y revenue/share CAGR under 50% of 3391.T's 178.94%. Michael Burry would suspect a lasting competitive disadvantage.
44.56%
5Y revenue/share CAGR 1.25-1.5x 3391.T's 35.93%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
20.69%
3Y revenue/share CAGR 1.25-1.5x 3391.T's 17.70%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
23.06%
Below 50% of 3391.T's 108.01%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
21.77%
5Y net income/share CAGR above 1.5x 3391.T's 2.27%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-8.85%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
138.51%
10Y equity/share CAGR at 75-90% of 3391.T's 169.54%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
97.30%
5Y equity/share CAGR above 1.5x 3391.T's 49.81%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
46.99%
3Y equity/share CAGR above 1.5x 3391.T's 21.38%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
88.89%
Dividend/share CAGR of 88.89% while 3391.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
No Data
No Data available this quarter, please select a different quarter.
-2.02%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.88%
Inventory is declining while 3391.T stands at 1.96%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.52%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.65%
BV/share growth above 1.5x 3391.T's 0.21%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
73.31%
Debt growth far above 3391.T's 0.32%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.35%
We cut SG&A while 3391.T invests at 1.26%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.